Technology
Health
Pharmaceutical
Prestige Consumer Healthcare
$29.799876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.42 (1.43%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell PBH and other stocks, options, ETFs, and crypto commission-free!
About
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. Read More The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Employees
520
Headquarters
Tarrytown, New York
Founded
1996
Market Cap
1.54B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
537.92K
High Today
$29.87
Low Today
$29.26
Open Price
$29.58
Volume
49.79K
52 Week High
$41.76
52 Week Low
$26.25
Collections
Technology
Health
Pharmaceutical
Healthcare
Advertising and Marketing
Consumer Products
Business Services
Retail
News
Yahoo FinanceMay 13
Prestige Consumer Healthcare Inc Files 10-K for the Fiscal Year Ended on March 31, 2019
- By insider Prestige Consumer Healthcare Inc (PBH) files its latest 10-K with SEC for the fiscal year ended on March 31, 2019. Prestige Brands Holdings Inc is a healthcare company. Its core business involves the distribution of healthcare and household cleaning products to supermarkets and drug stores. Prestige Consumer Healthcare Inc has a market cap of $1.56 billion; its shares were traded at around $30.19 with a P/E ratio of 24.74 and P/S ratio of 1.61. Prestige Consumer Healthcare Inc had annual a...
Yahoo FinanceMay 10
Prestige Consumer Q4 Earnings & Sales Beat Estimates
Prestige Consumer Healthcare, Inc. PBH came out with fourth-quarter fiscal 2019 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate. Shares of the company gained 2.7% on the better-than-expected results. While the bottom line grew year over year, sales declined for the fourth straight quarter. Dismal sales trend has caused this Zacks Rank #4 (Sell) stock to fall 14% in a year’s time, underperforming the industry’s decline of 10.9%. Q4 Details The company posted adj...
Price Paid on Robinhood
13% Lower
Right Now
52 Week Low
$26.25
Average Price Paid
$34.07
52 Week High
$41.76
Earnings
$0.61
$0.65
$0.70
$0.74
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
—
Actual
Expected Aug 1, Pre-Market